Stocks rose sharply on Thursday after the Federal Reserve hinted at possible interest rate cuts as soon as next month.US Marketsread more
The billionaire investor believes the stock market is in a "zone of fair value" at current levels.Marketsread more
The Federal Reserve may be on its way to delivering a half-point interest rate cut next month, according to Goldman Sachs economists.Economyread more
However, Slack chief Stewart Butterfield says, "The broader world of email will stick around."Technologyread more
Crude oil prices jump on news of the attack, which Iran says happened over its territory.World Politicsread more
Apple is considering moving some production from China as it is expected release of its new iPhone line this fall, The Wall Street Journal reported.Technologyread more
Workplace messaging firm Slack is about to go public in a red-hot IPO market, but it's approach to going public--using a "direct listing"--is slightly different than an IPO.Trader Talk with Bob Pisaniread more
The yield on the benchmark 10-year Treasury note fell below 2% for the first time since November 2016 on Wednesday.Bondsread more
National Securities' Art Hogan sees the U.S.-China trade war as the market's biggest risk – not Fed policy.Trading Nationread more
The Philadelphia Federal Reserve's manufacturing gauge tumbled this month, solidifying the Fed's case for easier monetary policy.Economyread more
Declining traffic to Olive Garden, Darden's top restaurant chain, resulted in weaker-than-expected revenue for its fiscal fourth quarter.Restaurantsread more
The family dynasty that owns Purdue Pharma in Stamford, Connecticut, is a major benefactor to charity.
Now, money from the Sackler family has become radioactive in the world of high-profile nonprofits and museums. In fact, cultural institutions like the Metropolitan Museum and Guggenheim in New York and the Tate in London have stopped accepting gifts from Sackler family members.
Why would nonprofits refuse such a big donor? Because the same family that funded these institutions for decades now finds itself at the center of the opioid crisis in the United States. Purdue Pharma created OxyContin, an opioid-based painkiller many believe is at the root of America's opioid epidemic, killing thousands across the U.S.
"While the allegations against our family are false and unfair, we understand that accepting gifts at this time would put the Met in a difficult position," a Sackler family spokesperson told CNBC. "We respect the Met and that is the last thing we would want to do. Our goal has always been to support the valuable work of such outstanding organizations, and we remain committed to doing so."
Meanwhile, as lawsuits pile up against Purdue and the Sackler family, the company continues to deny any wrongdoing. The spokesman for the family said the lawsuits are "baseless" and "inconsistent with the factual record."
But that hasn't stopped the lawsuits, and may lead the company to file for bankruptcy.
Arthur M. Sackler, brother of Mortimer and Raymond Sackler, died in 1987, years before OxyContin hit the market. His widow, Jillian, said in a statement that Arthur and his heirs have never benefited from the sale of OxyContin.
EDITOR'S NOTE: This story was updated on June 18, 2019, with a statement from Arthur M. Sackler's widow.